Trust Point’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$413K Buy
1,342
+62
+5% +$19.2K 0.03% 300
2026
Q2
$358K Sell
1,280
-19
-1% -$5K 0.03% 298
2026
Q1
$347K Sell
1,299
-116
-8% -$31.4K 0.03% 343
2025
Q4
$355K Sell
1,415
-28
-2% -$7.44K 0.03% 323
2025
Q3
$414K Buy
1,443
+188
+15% +$50.4K 0.03% 275
2025
Q2
$329K Buy
1,255
+27
+2% +$6.58K 0.03% 276
2025
Q1
$286K Buy
1,228
+6
+0.5% +$1.46K 0.03% 354
2024
Q4
$280K Sell
1,222
-17
-1% -$3.9K 0.02% 453
2024
Q3
$277K Buy
1,239
+10
+0.8% +$2.2K 0.02% 418
2024
Q2
$250K Sell
1,229
-170
-12% -$34.6K 0.02% 424
2024
Q1
$306K Sell
1,399
-7
-0.5% -$1.54K 0.02% 405
2023
Q4
$320K Buy
+1,406
New +$295K 0.03% 385

Other funds holding LH

Trust Point's LH Position: Q3 2026 in Review

Trust Point increased its Labcorp (LH) stake by 4.8% in Q3 2026, buying an estimated $19.2K and bringing the position to 1,342 shares worth $413K. The position accounts for 0.03% of the portfolio, ranked #300.

Trust Point first reported a position in LH in Q4 2023 and has held it in 12 quarters since. The position peaked at $414K in Q3 2025. 925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Trust Point held 1,342 shares of Labcorp worth $413K as of Q3 2026.
  • Trust Point bought 62 Labcorp shares in Q3 2026, an estimated $19.2K.
  • Labcorp made up 0.03% of Trust Point's portfolio in Q3 2026, its #300 holding.
  • Trust Point first reported a position in Labcorp in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Labcorp position peaked at $414K in Q3 2025.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.